A Multifactorial Multidrug Resistance Gene Set Predicts Overall Survival In Ovarian Primary Serous Carcinoma Read more about A Multifactorial Multidrug Resistance Gene Set Predicts Overall Survival In Ovarian Primary Serous Carcinoma US Application 61/308,946Filed on 2010-02-27
Prostate Tumor-Associcated Dendritic Cell Induction of Tolerance and Suppressor Activity in Tumor... - Read more about Prostate Tumor-Associcated Dendritic Cell Induction of Tolerance and Suppressor Activity in Tumor... - US Application 61/293,098Filed on 2010-01-07
Modulating Immune Cell Activity Using Cylokine-induced Src Homology 2 And/Or High Temperature Requirement A-1 Read more about Modulating Immune Cell Activity Using Cylokine-induced Src Homology 2 And/Or High Temperature Requirement A-1 US Application 61/420,825Filed on 2010-12-08
Device And Method For Ensuring The Accuracy Of A Tracking Device In A Volume Read more about Device And Method For Ensuring The Accuracy Of A Tracking Device In A Volume US Application 60/626,947Filed on 2004-11-12
Use Of Cucurbitacins And Withanolides To Sensitize Cancer Cells To The Cytotoxic Effects Of Apo2L/TRAIL Read more about Use Of Cucurbitacins And Withanolides To Sensitize Cancer Cells To The Cytotoxic Effects Of Apo2L/TRAIL US Application 61/287,139Filed on 2009-12-16
Development Of Novel Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain:Part 2 Read more about Development Of Novel Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain:Part 2 US Application 61/300,349Filed on 2010-02-01
Novel Nitroxyl (HNO) Prodrugs And Biomedical Applications Thereof Read more about Novel Nitroxyl (HNO) Prodrugs And Biomedical Applications Thereof US Application 61/315,604Filed on 2010-03-19
Development Of A Vaccine Composed Of CpG Oligonucleolides Conjugated To Apoptotic Tumor Cells To Treat Cancer. Read more about Development Of A Vaccine Composed Of CpG Oligonucleolides Conjugated To Apoptotic Tumor Cells To Treat Cancer. US Application 61/309,802Filed on 2010-03-02
Diagnosis and Treatment of Cancer Through NUAK2 Assessment and Modulation Read more about Diagnosis and Treatment of Cancer Through NUAK2 Assessment and Modulation US Application 61/321,136Filed on 2010-04-05
Nitric Oxide-based Cancer Therapeutic Agents For Lung Cancers With Elevated Levels Of Reactive Oxygen Species (ROS) And/or Low Levels Of Antioxidant Defense/DNA Repair mechanisms. Read more about Nitric Oxide-based Cancer Therapeutic Agents For Lung Cancers With Elevated Levels Of Reactive Oxygen Species (ROS) And/or Low Levels Of Antioxidant Defense/DNA Repair mechanisms. US Application 61/261,175Filed on 2009-11-13